CHAPTER 7 Methods for detection of HPV infection and its clinical utility. (Q54573717)

1 June 2018

title

CHAPTER 7 Methods for detection of HPV infection and its clinical utility. (English)

1 reference

1 June 2018

author name string

Luisa Lina Villa

series ordinal

1

1 reference

1 June 2018

Lynette Denny

series ordinal

2

1 reference

1 June 2018

publication date

1 November 2006

1 reference

1 June 2018

International Journal of Gynecology and Obstetrics

published in

1 reference

1 June 2018

volume

94 Suppl 1

1 reference

1 June 2018

page(s)

S71-S80

1 reference

1 June 2018

Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Diagnosis and management of oncogenic cervical human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Natural history of cervicovaginal papillomavirus infection in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Human papillomavirus DNA testing for cervical cancer screening in low-resource settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Management of women who test positive for high-risk types of human papillomavirus: the HART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Two-stage cervical cancer screening: an alternative for resource-poor settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

2001 Consensus Guidelines for the management of women with cervical cytological abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Viral load as a predictor of the risk of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Chapter 12: Human papillomavirus technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Short-term fluctuations in the detection of cervical human papillomavirus DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Persistence of type-specific human papillomavirus infection among cytologically normal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Human papillomavirus infection is transient in young women: a population-based cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

Screening for cervical cancer: new alternatives and research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2807%2960013-7

10.1016/S0020-7292(07)60013-7

7 January 2021

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

29644640

1 reference

1 June 2018